The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Chitosan for overweight or obesity
|
---|---|
Published in |
Cochrane database of systematic reviews, July 2008
|
DOI | 10.1002/14651858.cd003892.pub3 |
Pubmed ID | |
Authors |
Andrew B Jull, Cliona Ni Mhurchu, Derrick A Bennett, Christel AE Dunshea‐Mooij, Anthony Rodgers |
Abstract |
Chitosan, a deacetylated chitin, is a dietary supplement reported to decrease body weight. It is widely available over the counter worldwide and although evaluated in a number of trials its efficacy remains in dispute. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Egypt | 1 | 13% |
Turkey | 1 | 13% |
Unknown | 6 | 75% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 75% |
Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 452 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 2 | <1% |
United States | 2 | <1% |
Ireland | 1 | <1% |
Germany | 1 | <1% |
United Kingdom | 1 | <1% |
India | 1 | <1% |
Singapore | 1 | <1% |
Canada | 1 | <1% |
Unknown | 442 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 77 | 17% |
Student > Master | 73 | 16% |
Researcher | 47 | 10% |
Student > Ph. D. Student | 40 | 9% |
Student > Postgraduate | 21 | 5% |
Other | 87 | 19% |
Unknown | 107 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 160 | 35% |
Agricultural and Biological Sciences | 40 | 9% |
Nursing and Health Professions | 37 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 14 | 3% |
Unspecified | 13 | 3% |
Other | 66 | 15% |
Unknown | 122 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2024.
All research outputs
#1,300,531
of 25,711,998 outputs
Outputs from Cochrane database of systematic reviews
#2,729
of 13,134 outputs
Outputs of similar age
#2,934
of 96,714 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 65 outputs
Altmetric has tracked 25,711,998 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,134 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,714 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.